Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology USA
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
Release Date:
Review Process:
Improving the Clinical Management of Uncontrolled Acromegaly
Release Date:
Review Process:
Antimicrobial Stewardship in the Asia-Pacific Region
Release Date:
Review Process:
Lysosomal Storage Disorders Fellowship for Nurse Practitioners
Release Date:
Review Process:
Hemophilia PUP Registry
Release Date:
Review Process:
Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and Management
Release Date:
Review Process:
Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
Release Date:
Review Process:
Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic Arthritis
Release Date:
Review Process:
Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE)
Release Date:
Review Process:
Medication Optimization in Primary Care
Release Date:
Review Process:
Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
Release Date:
Review Process:
Increasing Rates of BRCA Testing in Patients with Breast Cancer
Release Date:
Review Process: